Download PDF

Other users also viewed these articles

Prevalence and risk factors of significant fibrosis in chronic hepatitis B patients with concurrent metabolic dysfunction-associated steatotic liver disease Shan Hong; Yiwei Hao; Lei Sun; Ping Li; Junru Yang; Fuyang Zhang; Lingling He; Jing Zhang; Hongshan Wei;
10.1016/j.aohep.2024.101589
The steatosis-associated fibrosis estimator (SAFE) outperformed the FIB-4 score in screening the population for liver disease Mingkai Li; Ying Lin; Hongsheng Yu; Weichun Lin; Jianning Chen; Yidong Yang; Bin Wu;
10.1016/j.aohep.2024.101516
Diagnostic accuracy of blood biomarkers and non-invasive scores for the diagnosis of NAFLD and NASH: Systematic review and meta-analysis Daniela Contreras; Alejandra González-Rocha; Patricia Clark; Simón Barquera; Edgar Denova-Gutiérrez;
Ann Hepatol. 2023;28: